Gala Pharmaceutical Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Gala Pharmaceutical Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $158.74 thousand as of 2014-08-31, per its 10-Q filed 2014-10-20.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-10-20
- 2014-08-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $158.74K.
- 2014-05-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $121.76K.
- 2014-02-28: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $116.66K.
- 2013-11-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $108.20K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-08-31 | $158.74K 10-Q · filed 2014-10-20 | |
| 2014-05-31 | $121.76K 10-Q · filed 2014-07-18 | |
| 2014-02-28 | $116.66K 10-Q · filed 2014-04-28 | |
| 2013-11-30 | $108.20K 10-Q · filed 2014-10-20 | |
| 2013-08-31 | $96.39K 10-Q · filed 2013-10-29 | |
| 2013-05-31 | $90.74K 10-Q · filed 2013-07-19 | |
| 2013-02-28 | $82.31K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $72.21K 10-K · filed 2014-04-18 | |
| 2012-08-31 | $43.05K 10-Q · filed 2012-10-15 | |
| 2012-05-31 | $23.91K 10-Q · filed 2012-07-18 | |
| 2012-02-29 | -$23.03K 10-Q · filed 2012-04-23 | |
| 2011-11-30 | $20.07K 10-K · filed 2013-03-14 | -$20.07K 10-K · filed 2012-03-13 |
| 2011-08-31 | -$8.31K 10-Q/A · filed 2011-11-09 | |
| 2010-11-30 | -$621.00 10-K · filed 2012-03-13 |